Related Experiment Videos
[Application of endolaser in vitrectomy for retinal vascular disease]
Jing Zang1, Binbing Zhou, Jionglin Bao
1Guangzhou Railway Central Hospital, Guangzhou 510080, China.
Purpose:
To discuss the usage and effectiveness of endolaser in vitrectomy for retinal vascular disease.
Methods:
Twenty-four cases (28 eyes) of vitrectomy for retinal vascular disease were treated with endolaser. The methods of endolaser: 21 eyes were treated with panretinal scatter therapy; 2 eyes with endolaser ring-intercepting around retinal and sealing retinal breaks; 5 eye with focal therapy.
Results:
After follow-up for 1-24 months (mean 9 months), retinal hemorrhage recurred in 3 eyes; the other 25 eyes, retinas were totally reattached, retinal breaks were sealed, and vision had considerable recovery, no hemorrhage. The ratio of recovery is up to 89.2%.
Conclusions:
Endolaser is an important adjuvant in vitreous operation nowadays and an effective procedure in vitrectomy for the cases of retinal hemorrhage.